Here's the write up from when he joined Dr Rick Kendall Based in...

Here's the write up from when he joined

Dr Rick Kendall
Based in California, Dr Kendall is currently Vice President Research at Kite Pharma,
responsible for the company’s research pipeline and developing CAR-T technology.
Previously, Dr Kendall was Executive Director of Oncology Research at Amgen, where
he directed a group of 90+ scientists, and was responsible for the development of the
Amgen cancer franchise strategy aligning research with other functions including
Chemistry, Protein Sciences, Medical Translational Sciences, Development and
Commercial. Results included 17 clinical candidate molecules made up of 9 small
molecules and 8 protein therapeutics. Dr Kendall holds an associate adjunct professor
position in the Department of Molecular, Cellular and Developmental Biology, at the
University of California at Santa Barbara.
Dr Kendall has consulted to Phylogica in recent months on the development of the
company’s assets including the iMyc oncology program and Functional Penetrating
Phylomer (FPP) intracellular drug delivery technology.
Dr Kendall has commented. “I am pleased to join the Phylogica Board and contribute
to the goal of developing Phylogica’s innovative technology to target previously
intractable targets important in cancer and other diseases with high unmet medical
need.”

I wonder if he was still based in California and they have gone with someone who wantwd to be in oz. Either way if tech was omg one would think he would drop everything.
Hes still at Kite and prefers that